Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP783664.RAkMfqbOEx9JXHnu38n6kdvqYtty6d-d30a7qKNvrMt50130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP783664.RAkMfqbOEx9JXHnu38n6kdvqYtty6d-d30a7qKNvrMt50130_assertion type Assertion NP783664.RAkMfqbOEx9JXHnu38n6kdvqYtty6d-d30a7qKNvrMt50130_head.
- NP783664.RAkMfqbOEx9JXHnu38n6kdvqYtty6d-d30a7qKNvrMt50130_assertion description "[Targeted disruption of FANCC and FANCG in human cancer provides a preclinical model for specific therapeutic options.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP783664.RAkMfqbOEx9JXHnu38n6kdvqYtty6d-d30a7qKNvrMt50130_provenance.
- NP783664.RAkMfqbOEx9JXHnu38n6kdvqYtty6d-d30a7qKNvrMt50130_assertion evidence source_evidence_literature NP783664.RAkMfqbOEx9JXHnu38n6kdvqYtty6d-d30a7qKNvrMt50130_provenance.
- NP783664.RAkMfqbOEx9JXHnu38n6kdvqYtty6d-d30a7qKNvrMt50130_assertion SIO_000772 16762635 NP783664.RAkMfqbOEx9JXHnu38n6kdvqYtty6d-d30a7qKNvrMt50130_provenance.
- NP783664.RAkMfqbOEx9JXHnu38n6kdvqYtty6d-d30a7qKNvrMt50130_assertion wasDerivedFrom befree-20140225 NP783664.RAkMfqbOEx9JXHnu38n6kdvqYtty6d-d30a7qKNvrMt50130_provenance.
- NP783664.RAkMfqbOEx9JXHnu38n6kdvqYtty6d-d30a7qKNvrMt50130_assertion wasGeneratedBy ECO_0000203 NP783664.RAkMfqbOEx9JXHnu38n6kdvqYtty6d-d30a7qKNvrMt50130_provenance.